Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 1
2005 1
2006 2
2007 4
2008 7
2009 5
2010 4
2011 3
2012 5
2013 8
2014 6
2015 5
2016 3
2017 3
2018 5
2019 2
2020 5
2021 9
2022 13
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Results by year

Filters applied: . Clear all
Page 1
T-cell immunophenotype correlations with cortical thickness and white matter microstructure in bipolar disorder.
Escelsior A, Inuggi A, Sterlini B, Bovio A, Marenco G, Bode J, Favilla L, Tardito S, Altosole T, Pereira da Silva B, Fenoglio D, Filaci G, Amore M, Serafini G. Escelsior A, et al. Among authors: filaci g. J Affect Disord. 2024 Mar 1;348:179-190. doi: 10.1016/j.jad.2023.12.054. Epub 2023 Dec 26. J Affect Disord. 2024. PMID: 38154587 Free article.
Targets and cross-reactivity of human T cell recognition of common cold coronaviruses.
Tarke A, Zhang Y, Methot N, Narowski TM, Phillips E, Mallal S, Frazier A, Filaci G, Weiskopf D, Dan JM, Premkumar L, Scheuermann RH, Sette A, Grifoni A. Tarke A, et al. Among authors: filaci g. Cell Rep Med. 2023 Jun 20;4(6):101088. doi: 10.1016/j.xcrm.2023.101088. Epub 2023 May 29. Cell Rep Med. 2023. PMID: 37295422 Free PMC article.
Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells.
Amaro A, Reggiani F, Fenoglio D, Gangemi R, Tosi A, Parodi A, Banelli B, Rigo V, Mastracci L, Grillo F, Cereghetti A, Tastanova A, Ghosh A, Sallustio F, Emionite L, Daga A, Altosole T, Filaci G, Rosato A, Levesque M, Maio M, Pfeffer U, Croce M; EPigenetic Immune-oncology Consortium Airc (EPICA) consortium. Amaro A, et al. Among authors: filaci g. J Exp Clin Cancer Res. 2023 Mar 18;42(1):67. doi: 10.1186/s13046-023-02628-x. J Exp Clin Cancer Res. 2023. PMID: 36934257 Free PMC article.
Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19.
Baldi F, Dentone C, Mikulska M, Fenoglio D, Mirabella M, Magnè F, Portunato F, Altosole T, Sepulcri C, Giacobbe DR, Uras C, Scavone G, Taramasso L, Orsi A, Cittadini G, Filaci G, Bassetti M. Baldi F, et al. Among authors: filaci g. Front Med (Lausanne). 2023 Jan 9;9:1062450. doi: 10.3389/fmed.2022.1062450. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36698815 Free PMC article.
Trojan-horse silk fibroin nanocarriers loaded with a re-call antigen to redirect immunity against cancer.
Bari E, Ferrera F, Altosole T, Perteghella S, Mauri P, Rossi R, Passignani G, Mastracci L, Galati M, Astone GI, Mastrogiacomo M, Castagnola P, Fenoglio D, Di Silvestre D, Torre ML, Filaci G. Bari E, et al. Among authors: filaci g. J Immunother Cancer. 2023 Jan;11(1):e005916. doi: 10.1136/jitc-2022-005916. J Immunother Cancer. 2023. PMID: 36697251 Free PMC article.
Targets and cross-reactivity of human T cell recognition of Common Cold Coronaviruses.
Tarke A, Zhang Y, Methot N, Narowski TM, Phillips E, Mallal S, Frazier A, Filaci G, Weiskopf D, Dan JM, Premkumar L, Scheuermann RH, Sette A, Grifoni A. Tarke A, et al. Among authors: filaci g. bioRxiv [Preprint]. 2023 Jan 5:2023.01.04.522794. doi: 10.1101/2023.01.04.522794. bioRxiv. 2023. PMID: 36656777 Free PMC article. Updated. Preprint.
92 results